Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database
- 571 Downloads
The aim of this study was to integrate European epidemiological data on patients with multiple endocrine neoplasia type 1 by creating an Italian registry of this syndrome, including clinical and genetic characteristics and therapeutic management.
Clinical, familial and genetic data of patients with multiple endocrine neoplasia type 1, diagnosed, treated, and followed-up for a mean time of 11.3 years, in 14 Italian referral endocrinological centers, were collected, over a 3-year course (2011–2013), to build a national electronic database.
The Italian multiple endocrine neoplasia type 1 database includes 475 patients (271 women and 204 men), of whom 383 patients (80.6%) were classified as familial cases (from 136 different pedigrees), and 92 (19.4%) patients were sporadic cases. A MEN1 mutation was identified in 92.6% of familial cases and in 48.9% of sporadic cases. Four hundred thirty-six patients were symptomatic, presenting primary hyperparathyroidism, gastroenteropancreatic neuroendocrine tumors and pituitary tumors in 93, 53, and 41% of cases, respectively. Thirty-nine subjects, belonging to affected pedigrees positive for a MEN1 mutation, were asymptomatic at clinical and biochemical screening. Age at diagnosis of multiple endocrine neoplasia type 1 probands was similar for both familial and simplex cases (mean age 47.2 ± 15.3 years). In familial cases, diagnosis of multiple endocrine neoplasia type 1 in relatives of affected probands was made more than 10 years in advance (mean age at diagnosis 36.5 ± 17.6 years).
The analysis of Italian registry of multiple endocrine neoplasia type 1 patients revealed that clinical features of Italian multiple endocrine neoplasia type 1 patients are similar to those of other western countries, and confirmed that the genetic test allowed multiple endocrine neoplasia type 1 diagnosis 10 years earlier than biochemical or clinical diagnosis.
KeywordsMEN1 Italian registry Pituitary adenomas Gastroenteropancreatic tumors Primary hyperparathyroidism MEN1 genetic test
This study was supported by one unrestricted grant from Fondazione Ente Cassa di Risparmio di Firenze to ML Brandi, and by AIMEN 1 & 2. There is no funding associated with this publication.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no competing interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 2.S.C. Chandrasekharappa, S.C. Guru, P. Manickam, S.E. Olufemi, F.S. Collins, M.R. Emmert-Buck, L.V. Debelenko, Z. Zhuang, I.A. Lubensky, L.A. Liotta, J.S. Crabtree, Y. Wang, B.A, Roe, J. Weisemann, M.S. Boguski, S.K. Agarwal, M.B. Kester, Y.S. Kim, C. Heppner, Q. Dong, A.M. Spiegel, A.L. Burns, S.J. Marx, Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276(5311), 404–407 (1997)CrossRefPubMedGoogle Scholar
- 3.M.L. Brandi, R.F. Gagel, A. Angeli, J.P. Bilezikian, P. Beck-Peccoz, C. Bordi, B. Conte-Devolx, A. Falchetti, R.G. Gheri, A. Libroia, C.J. Lips, G. Lombardi, M. Mannelli, F. Pacini, B.A. Ponder, F. Raue, B. Skogseid, G. Tamburrano, R.V. Thakker, N.W. Thompson, P. Tomassetti, F. Tonelli, S.A. Wells Jr., S.J. Marx, Guidelines for diagnosis and therapy of MEN type 1 and type 2. J. Clin. Endocrinol. Metab. 86(12), 5658–5671 (2001)CrossRefPubMedGoogle Scholar
- 10.J.J. Turner, P.D. Leotlela, A.A. Pannett, S.A. Forbes, J.H. Bassett, B. Harding, P.T. Christie, D. Bowen-Jones, S. Ellard, A. Hattersley, C.E. Jackson, R. Pope, O.W. Quarrell, R. Trembath, R.V. Thakker, Frequent occurrence of an intron 4 mutation in multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab. 87, 2688–2693 (2002)CrossRefPubMedGoogle Scholar
- 11.V. Wautot, C. Vercherat, J. Lespinasse, B. Chambe, G.M. Lenoir, C.X. Zhang, N. Porchet, M. Cordier, C. Beroud, A. Calender, Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein. Hum. Mutat. 20, 35–47 (2002)CrossRefPubMedGoogle Scholar
- 13.J. Thevenon, A. Bourredjem, L. Faivre, C. Cardot-Bauters, A. Calender, A. Murat, S. Giraud, P. Niccoli, M.F. Odou, F. Borson-Chazot et al. Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d’etude des Tumeurs Endocrines (GTE) cohort study. Hum. Mol. Genet. 22(10), 1940–1948 (2013)CrossRefPubMedGoogle Scholar
- 14.J. Thevenon, A. Bourredjem, L. Faivre, C. Cardot-Bauters, A. Calender, M. Le Bras, S. Giraud, P. Niccoli, M.F. Odou, F. Borson-Chazot et al. Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d’étude des Tumeurs Endocrines study. Eur. J. Endocrinol. 173(6), 819–826 (2015)CrossRefPubMedGoogle Scholar
- 15.V. Ramundo, F. Milone, R. Severino, S. Savastano, C. Di Somma, L. Vuolo, L. De Luca, G. Lombardi, A. Colao, A. Faggiano, Clinical and prognostic implications of the genetic diagnosis of hereditary NET syndromes in asymptomatic patients. Horm. Metab. Res. 43(11), 794–780 (2011)CrossRefPubMedGoogle Scholar
- 16.B. Gatta-Cherifi, O. Chabre, A. Murat, P. Niccoli, C. Cardot-Bauters, V. Rohmer, J. Young, B. Delemer, H. Du Boullay, M.F. Verger, J.M. Kuhn, J.L. Sadoul, P. Ruszniewski, A. Beckers, M. Monsaingeon, E. Baudin, P. Goudet, A. Tabarin, Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d’etude des Tumeurs Endocrines database. Eur. J. Endocrinol. 166(2), 269–279 (2012)CrossRefPubMedGoogle Scholar
- 17.D. Vezzosi, C. Cardot-Bauters, N. Bouscaren, M. Lebras, M. Bertholon-Grégoire, P. Niccoli, N. Levy-Bohbot, L. Groussin, P. Bouchard, A. Tabarin, P. Chanson, P. Lecomte, I. Guilhem, N. Carrere, E. Mirallié, F. Pattou, J.L. Peix, D. Goere, F. Borson-Chazot, P. Caron, V. Bongard, B. Carnaille, P. Goudet, E. Baudin, Long-term results of the surgical management of insulinoma patients with MEN1: a Groupe d’étude des Tumeurs Endocrines (GTE) retrospective study. Eur. J. Endocrinol. 172(3), 309–319 (2015)CrossRefPubMedGoogle Scholar
- 18.J.M. De Laat, C.R. Pieterman, M.F. van den Broek, J.W. Twisk, A.R. Hermus, O.M. Dekkers, W.W. de Herder, A.N. van der Horst-Schrivers, M.L. Drent, P.H. Bisschop, B. Havekes, M.R. Vriens, G.D. Valk, Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patients. J. Clin. Endocrinol. Metab. 99(9), 3325–3333 (2014)CrossRefPubMedGoogle Scholar
- 19.J.M. De Laat, O.M. Dekkers, C.R. Pieterman, W.P. Kluijfhout, A.R. Hermus, A.M. Pereira, A.N. van der Horst-Schrivers, M.L. Drent, P.H. Bisschop, B. Havekes, W.W. de Herder, G.D. Valk, Long-term natural course of pituitary tumors in patients with MEN1: results from the DutchMEN1 study group (DMSG). J. Clin. Endocrinol. Metab. 100(9), 3288–3296 (2015)CrossRefPubMedGoogle Scholar
- 20.P. Goudet, C. Bonithon-Kopp, A. Murat, P. Ruszniewski, P. Niccoli, F. Ménégaux, G. Chabrier, F. Borson-Chazot, A. Tabarin, P. Bouchard, G. Cadiot, A. Beckers, I. Guilhem, O. Chabre, P. Caron, H. Du Boullay, B. Verges, C. Cardot-Bauters, Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d’etude des Tumeurs Endocrines. Eur. J. Endocrinol. 165(1), 97–105 (2011)CrossRefPubMedGoogle Scholar
- 22.Rare Diseases Task Force: Patients Registries in the field of rare diseases. http://www.eucerd.eu/?post_type=document&p=1218, accessed December 2016
- 23.A. Sakurai, S. Suzuki, S. Kosugi, T. Okamoto, S. Uchino, A. Miya, T. Imai, H. Kaji, I. Komoto, D. Miura, M. Yamada, T. Uruno, K. Horiuchi, A. Miyauchi, M. Imamura; MEN Consortium of Japan, T. Fukushima, K. Hanazaki, S. Hirakawa, T. Igarashi, T. Iwatani, M. Kammori, T. Katabami, M. Katai, T. Kikumori, K. Kiribayashi, S. Koizumi, S. Midorikawa, R. Miyabe, T. Munekage, A. Ozawa, K. Shimizu, I. Sugitani, H. Takeyama, M. Yamazaki, Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database. Clin. Endocrinol. 76(4), 533–539 (2012)CrossRefGoogle Scholar
- 24.A. Sakurai, M. Yamazaki, S. Suzuki, T. Fukushima, T. Imai, T. Kikumori, T. Okamoto, K. Horiuchi, S. Uchino, S. Kosugi, M. Yamada, I. Komoto, K. Hanazaki, M. Itoh, T. Kondo, M. Mihara, M. Imamura, Clinical features of insulinoma in patients with multiple endocrine neoplasia type 1: analysis of the database of the MEN Consortium of Japan. Endocr. J. 59(10), 859–866 (2012)CrossRefPubMedGoogle Scholar
- 25.C.R. Pieterman, J.M. Schreinemakers, H.P. Koppeschaar, M.R. Vriens, I.H. Rinkes, B.A. Zonnenberg, R.B. van der Luijt, G.D. Valk, Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome. Clin. Endocrinol. 70(4), 575–581 (2009)CrossRefGoogle Scholar
- 27.T.C. Lairmore, L.D. Piersall, M.K. DeBenedetti, W.G. Dilley, M.G. Mutch, A.J. Whelan, B. Zehnbauer, Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1). Ann. Surg. 239(5), 637–645 discussion 645–647. (2004)CrossRefPubMedPubMedCentralGoogle Scholar
- 29.R.S. Van Leeuwaarde, B.P. van Nesselrooij, A.R. Hermus, O.M. Dekkers, W.W. de Herder, A.N. van der Horst-Schrivers, M.L. Drent, P.H. Bisschop, B. Havekes, M.R. Vriens, J.M. de Laat, C.R. Pieterman, G.D. Valk, Impact of delay in diagnosis in outcomes in MEN1: results from the Dutch MEN1 study group. J. Clin. Endocrinol. Metab. 101(3), 1159–1165 (2016)CrossRefPubMedGoogle Scholar